New Delhi, Oct. 23 -- Aurobindo Pharma Limited on Thursday announced the incorporation of a new wholly-owned subsidiary, Eugia Pharma Chile SpA, in Chile, marking a strategic move to expand its pharmaceutical business in South America.

Eugia Pharma Chile SpA is a wholly-owned stepdown subsidiary of Eugia Pharma B.V, which is itself entirely owned by Aurobindo Pharma. The Chilean company was officially incorporated on October 7, 2025, with signed formation documents received on October 22, 2025. This initiative is part of Aurobindo Pharma's broader strategy to strengthen its presence in international markets, particularly in the pharmaceutical sector, it said in a stock exchange filing.

The transaction involves a 100% cash subscription t...